China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized controlled clinical study of Rui Anning versus OxyContin for the treatment of moderate-to-severe cancer pain'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129724
Registration Time: 2026/08/09
Type: Interventional study
Primary Sponsor: Beijing Friendship Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=326599
Published by HT Digital Content Services with permission from Health Daily Digest....